Approximately 75% of all breast cancers grow in response to the hormone estrogen. An additional 65% of cancers also
grow in response to the hormone progesterone. A targeted
therapy that prevents activation of estrogen and progesterone
receptors in breast cancer would be beneficial to which type
of patient?

In which the cause of cancer is the estrogen and progesterone hormones.

Explanation:

A targeted  therapy that prevents activation of estrogen and progesterone  receptors in breast cancer would be beneficial to the type  of patient in which the breast cancer occurs due to estrogen and progesterone hormones. Targeted therapy is a type of therapy that uses drugs or other substances to  attack certain types of cancer cells. This therapy deactivated estrogen and progesterone hormones which is the cause of cancer disease in patient.